맞춤형 의료 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The global personalized medicine market size is expected to reach USD 1260.90 Billion in 2034 from USD 441.75 Billion in 2025, growing at a CAGR of 12.36% during 2026-2034.The Personalized Medicine Market is poised for significant growth as advancements in genomics and biotechnology enable tailored healthcare solutions. Personalized medicine involves customizing medical treatment based on individual characteristics, such as genetic makeup, lifestyle, and environmental factors. The increasing prevalence of chronic diseases and the growing demand for targeted therapies are driving investments in personalized medicine, further propelling market expansion. Additionally, the emphasis on improving patient outcomes and reducing healthcare costs is contributing to the adoption of personalized approaches in treatment.

Technological advancements are playing a crucial role in shaping the future of the personalized medicine market. Innovations in genomic sequencing, bioinformatics, and data analytics are enhancing the ability to identify specific biomarkers and develop targeted therapies. Furthermore, the integration of artificial intelligence and machine learning is enabling healthcare providers to analyze vast amounts of data and make informed decisions regarding treatment options. As the industry continues to evolve, the personalized medicine market is likely to see increased adoption of technology-driven solutions across various healthcare settings.

Moreover, the growing emphasis on patient engagement and education is influencing the personalized medicine market's growth trajectory. As patients become more informed about their health and treatment options, there is a rising demand for personalized solutions that cater to their specific needs. This trend is driving collaboration between healthcare providers, pharmaceutical companies, and technology firms to develop educational resources and support systems that empower patients to take an active role in their healthcare decisions. As the market continues to evolve, the integration of technology, patient engagement, and personalized care will be key drivers of success.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Product

• Personalized Medicine Diagnostics (Genetic Testing, Biomarker Testing, Companion Diagnostics, Molecular Imaging)
• Personalized Medicine Therapeutics (Targeted Therapies, Gene Therapies, Monoclonal Antibodies, Cell and Gene Therapy Products)
• Personalized Medical Care (Tailored Treatment Plans, Patient-Centric Care Models, Digital Health Solutions, Remote Patient Monitoring)
• Personalized Nutrition and Wellness (Nutrigenomics, Customized Diet Plans, Supplement Personalization, Lifestyle Modification Programs)

By Application

• Oncology
• Neurology
• Blood Transfusion Safety
• Diabetes
• Autoimmune Diseases
• Cardiology
• Other Applications

By End-use

• Hospitals
• Diagnostic Centers
• Research and Academic Institutes
• Other End-Users

COMPANIES PROFILED

• Roche, Thermo Fisher Scientific, Illumina, QIAGEN, Abbott, Foundation Medicine, Guardant Health, Natera, Exact Sciences, Tempus AI, Invitae, NeoGenomics, Labcorp, Quest Diagnostics, Novartis, Pfizer, AstraZeneca, Merck, Bristol Myers Squibb, Johnson & Johnson

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL PERSONALIZED MEDICINE MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Personalized Medicine Diagnostics (Genetic Testing, Biomarker Testing, Companion Diagnostics, Molecular Imaging) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Personalized Medicine Therapeutics (Targeted Therapies, Gene Therapies, Monoclonal Antibodies, Cell and Gene Therapy Products) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Personalized Medical Care (Tailored Treatment Plans, Patient-Centric Care Models, Digital Health Solutions, Remote Patient Monitoring) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Personalized Nutrition and Wellness (Nutrigenomics, Customized Diet Plans, Supplement Personalization, Lifestyle Modification Programs) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL PERSONALIZED MEDICINE MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Oncology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Neurology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Blood Transfusion Safety Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Diabetes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Autoimmune Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Cardiology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.8. Other Applications Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL PERSONALIZED MEDICINE MARKET: BY END-USE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-use
• 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Diagnostic Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Research and Academic Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Other End-Users Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL PERSONALIZED MEDICINE MARKET: BY REGION 2022-2034 (USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product
  • 7.2.2 By Application
  • 7.2.3 By End-use
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product
  • 7.3.2 By Application
  • 7.3.3 By End-use
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Spain
  • 7.3.9 Russia
  • 7.3.10 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product
  • 7.4.2 By Application
  • 7.4.3 By End-use
  • 7.4.4 China
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 India
  • 7.4.8 Australia
  • 7.4.9 South East Asia
  • 7.4.10 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product
  • 7.5.2 By Application
  • 7.5.3 By End-use
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product
  • 7.6.2 By Application
  • 7.6.3 By End-use
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL PERSONALIZED MEDICINE INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Roche
  • 9.2.2 Thermo Fisher Scientific
  • 9.2.3 Illumina
  • 9.2.4 QIAGEN
  • 9.2.5 Abbott
  • 9.2.6 Foundation Medicine
  • 9.2.7 Guardant Health
  • 9.2.8 Natera
  • 9.2.9 Exact Sciences
  • 9.2.10 Tempus AI
  • 9.2.11 Invitae
  • 9.2.12 NeoGenomics
  • 9.2.13 Labcorp
  • 9.2.14 Quest Diagnostics
  • 9.2.15 Novartis
  • 9.2.16 Pfizer
  • 9.2.17 AstraZeneca
  • 9.2.18 Merck
  • 9.2.19 Bristol Myers Squibb
  • 9.2.20 Johnson & Johnson